Skip to main content

Table 2 Distribution of local-regional recurrences by constructed molecular subtype

From: Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

 

HR+/HER2-

N= 309

HR+/HER2+

N= 51

HR-/HER2+

N= 42

HR-/HER2-

N= 193

Local

4

2

4

14

Regional

4

1

1

5